Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Animals (2)
- Female (2)
- GABA-A (2)
- Male (2)
- Receptors (2)
-
- Receptors, GABA-A (2)
- Reinforcement (Psychology) (2)
- Time Factors (2)
- Adult (1)
- Benzodiazepines (1)
- Chlordiazepoxide (1)
- Cocaine (1)
- Cocaine-Related Disorders (1)
- Conditioning (1)
- Conditioning, Operant (1)
- Dose-Response Relationship (1)
- Dose-Response Relationship, Drug (1)
- Drug (1)
- Flumazenil (1)
- Follow-Up Studies (1)
- Food (1)
- GABA Antagonists (1)
- GABA Modulators (1)
- Humans (1)
- Imidazoles (1)
- Macaca mulatta (1)
- Midazolam (1)
- Middle Aged (1)
- Operant (1)
- Protein Subunits (1)
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
Randomized Clinical Trial Examining Duration Of Voucher-Based Reinforcement Therapy For Cocaine Abstinence., Kimberly C Kirby, Carolyn M Carpenedo, Karen L Dugosh, Beth J Rosenwasser, Lois A Benishek, Alicia Janik, Rachel Keashen, Elena Bresani, Kenneth Silverman
Randomized Clinical Trial Examining Duration Of Voucher-Based Reinforcement Therapy For Cocaine Abstinence., Kimberly C Kirby, Carolyn M Carpenedo, Karen L Dugosh, Beth J Rosenwasser, Lois A Benishek, Alicia Janik, Rachel Keashen, Elena Bresani, Kenneth Silverman
Faculty Scholarship for the College of Science & Mathematics
BACKGROUND: This is the first study to systematically manipulate duration of voucher-based reinforcement therapy (VBRT) to see if extending the duration increases abstinence during and following VBRT.
METHODS: We randomized cocaine-dependent methadone-maintained adults to Standard (12 weeks; n=62) or Extended (36 weeks; n=68) VBRT and provided escalating voucher amounts contingent upon urinalysis verification of cocaine abstinence. Urinalysis was scheduled at least every 2 weeks during the 48-week study and more frequently during VBRT (3/week) and 12 weeks of Aftercare (2/week).
RESULTS: Extended VBRT produced longer durations of continuous cocaine abstinence during weeks 1-24 (5.7 vs 2.7 weeks; p=0.003) and proportionally …
Role Of Gamma-Aminobutyric Acid Type A (Gabaa) Receptor Subtypes In Acute Benzodiazepine Physical Dependence-Like Effects: Evidence From Squirrel Monkeys Responding Under A Schedule Of Food Presentation., Bradford D Fischer, Laura P Teixeira, Michael L Van Linn, Ojas A Namjoshi, James M Cook, James K Rowlett
Role Of Gamma-Aminobutyric Acid Type A (Gabaa) Receptor Subtypes In Acute Benzodiazepine Physical Dependence-Like Effects: Evidence From Squirrel Monkeys Responding Under A Schedule Of Food Presentation., Bradford D Fischer, Laura P Teixeira, Michael L Van Linn, Ojas A Namjoshi, James M Cook, James K Rowlett
Cooper Medical School of Rowan University Faculty Scholarship
RATIONALE: Assays of schedule-controlled responding can be used to characterize the pharmacology of benzodiazepines and other GABAA receptor modulators, and are sensitive to changes in drug effects that are related to physical dependence.
OBJECTIVE: The present study used this approach to investigate the role of GABAA receptor subtypes in mediating dependence-like effects following benzodiazepine administration.
METHODS: Squirrel monkeys (n = 6) were trained on a fixed-ratio schedule of food reinforcement. Initially, the response rate-decreasing effects of chlordiazepoxide (0.1-10 mg/kg; nonselective GABAA receptor agonist), zolpidem (0.032-1.0 mg/kg; α1 subunit-containing GABAA subtype-preferring agonist), and HZ-166 (0.1-10 mg/kg; functionally selective α2 and α3 …
Reinforcing Effects Of Compounds Lacking Intrinsic Efficacy At Α1 Subunit-Containing Gabaa Receptor Subtypes In Midazolam- But Not Cocaine-Experienced Rhesus Monkeys., Nina M Shinday, Eileen K Sawyer, Bradford D Fischer, Donna M Platt, Stephanie C Licata, John R Atack, Gerard R Dawson, David S Reynolds, James K Rowlett
Reinforcing Effects Of Compounds Lacking Intrinsic Efficacy At Α1 Subunit-Containing Gabaa Receptor Subtypes In Midazolam- But Not Cocaine-Experienced Rhesus Monkeys., Nina M Shinday, Eileen K Sawyer, Bradford D Fischer, Donna M Platt, Stephanie C Licata, John R Atack, Gerard R Dawson, David S Reynolds, James K Rowlett
Cooper Medical School of Rowan University Faculty Scholarship
Benzodiazepines are prescribed widely but their utility is limited by unwanted side effects, including abuse potential. The mechanisms underlying the abuse-related effects of benzodiazepines are not well understood, although α1 subunit-containing GABAA receptors have been proposed to have a critical role. Here, we examine the reinforcing effects of several compounds that vary with respect to intrinsic efficacy at α2, α3, and α5 subunit-containing GABAA receptors but lack efficacy at α1 subunit-containing GABAA receptors ('α1-sparing compounds'): MRK-623 (functional selectivity for α2/α3 subunit-containing receptors), TPA023B (functional selectivity for α2/α3/α5 subunit-containing receptors), and TP003 (functional selectivity for α3 subunit-containing receptors). The reinforcing effects …